The epigenetics of epithelial-mesenchymal plasticity in cancer
During the course of malignant cancer progression, neoplastic cells undergo dynamic and reversible transitions between multiple phenotypic states, the extremes of which are defined by the expression of epithelial and mesenchymal phenotypes. This plasticity is enabled by underlying shifts in epigenet...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Nature Publishing Group
2018
|
| Online Access: | http://hdl.handle.net/1721.1/116944 https://orcid.org/0000-0002-0895-3557 |
| _version_ | 1826209407647612928 |
|---|---|
| author | Tam, Wai Leong Weinberg, Robert A |
| author2 | Massachusetts Institute of Technology. Department of Biology |
| author_facet | Massachusetts Institute of Technology. Department of Biology Tam, Wai Leong Weinberg, Robert A |
| author_sort | Tam, Wai Leong |
| collection | MIT |
| description | During the course of malignant cancer progression, neoplastic cells undergo dynamic and reversible transitions between multiple phenotypic states, the extremes of which are defined by the expression of epithelial and mesenchymal phenotypes. This plasticity is enabled by underlying shifts in epigenetic regulation. A small cohort of pleiotropically acting transcription factors is widely recognized to effect these shifts by controlling the expression of a constituency of key target genes. These master regulators depend on complex epigenetic regulatory mechanisms, notably the induction of changes in the modifications of chromatin-associated histones, in order to achieve the widespread changes in gene expression observed during epithelial-mesenchymal transitions (EMTs). These associations indicate that an understanding of the functional interactions between such EMT-inducing transcription factors and the modulators of chromatin configuration will provide crucial insights into the fundamental mechanisms underlying cancer progression and may, in the longer term, generate new diagnostic and therapeutic modalities for treating high-grade malignancies. |
| first_indexed | 2024-09-23T14:22:02Z |
| format | Article |
| id | mit-1721.1/116944 |
| institution | Massachusetts Institute of Technology |
| last_indexed | 2024-09-23T14:22:02Z |
| publishDate | 2018 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | mit-1721.1/1169442022-10-01T20:53:09Z The epigenetics of epithelial-mesenchymal plasticity in cancer Tam, Wai Leong Weinberg, Robert A Massachusetts Institute of Technology. Department of Biology Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology) Tam, Wai Leong Weinberg, Robert A During the course of malignant cancer progression, neoplastic cells undergo dynamic and reversible transitions between multiple phenotypic states, the extremes of which are defined by the expression of epithelial and mesenchymal phenotypes. This plasticity is enabled by underlying shifts in epigenetic regulation. A small cohort of pleiotropically acting transcription factors is widely recognized to effect these shifts by controlling the expression of a constituency of key target genes. These master regulators depend on complex epigenetic regulatory mechanisms, notably the induction of changes in the modifications of chromatin-associated histones, in order to achieve the widespread changes in gene expression observed during epithelial-mesenchymal transitions (EMTs). These associations indicate that an understanding of the functional interactions between such EMT-inducing transcription factors and the modulators of chromatin configuration will provide crucial insights into the fundamental mechanisms underlying cancer progression and may, in the longer term, generate new diagnostic and therapeutic modalities for treating high-grade malignancies. 2018-07-12T18:15:38Z 2018-07-12T18:15:38Z 2013-11 2013-04 2018-07-12T17:16:19Z Article http://purl.org/eprint/type/JournalArticle 1078-8956 1546-170X http://hdl.handle.net/1721.1/116944 Tam, Wai Leong, and Robert A Weinberg. “The Epigenetics of Epithelial-Mesenchymal Plasticity in Cancer.” Nature Medicine 19, 11 (November 2013): 1438–1449 © 2013 Nature America, Inc https://orcid.org/0000-0002-0895-3557 http://dx.doi.org/10.1038/NM.3336 Nature Medicine Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Nature Publishing Group PMC |
| spellingShingle | Tam, Wai Leong Weinberg, Robert A The epigenetics of epithelial-mesenchymal plasticity in cancer |
| title | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| title_full | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| title_fullStr | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| title_full_unstemmed | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| title_short | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| title_sort | epigenetics of epithelial mesenchymal plasticity in cancer |
| url | http://hdl.handle.net/1721.1/116944 https://orcid.org/0000-0002-0895-3557 |
| work_keys_str_mv | AT tamwaileong theepigeneticsofepithelialmesenchymalplasticityincancer AT weinbergroberta theepigeneticsofepithelialmesenchymalplasticityincancer AT tamwaileong epigeneticsofepithelialmesenchymalplasticityincancer AT weinbergroberta epigeneticsofepithelialmesenchymalplasticityincancer |